Back to Directory
VacTimmune
Northern Ireland
Founded 2025
Preclinical vaccines targeting antimicrobial-resistant bacterial infections
VacTimmune is a biotechnology company developing preventative vaccines against bacterial pathogens associated with antimicrobial resistance.
Its preclinical pipeline includes candidates targeting Pseudomonas aeruginosa, Klebsiella pneumoniae and other clinically important bacteria, with an emphasis on infections affecting vulnerable patients.
The company combines vaccine antigen discovery with laboratory testing and development work to progress candidates towards manufacturing, including quality-control assays for its lead vaccine programme.